He completed his residency training in psychiatry at Taipei Veterans General Hospital and became ... Lin E, Kuo PH, Liu YL, Yang AC, Kao CF, Tsai SJ.
Meet Our Editorial Board Member
Current Pharmacogenomics and Personalized Medicine, 2016, Vol. 14, No. 1 1
Meet Our Editorial Board Member Prof. Dr. Shih-Jen Tsai
School of Medicine National Yang-Ming University Taipei, Taiwan Shih-Jen Tsai, M.D., is Professor and Chair of the Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan. Dr. Tsai grew up in Taiwan. He graduated from National Yang-Ming University in 1986. Then he has two-year mandatory military service. He completed his residency training in psychiatry at Taipei Veterans General Hospital and became attending psychiatrist in 1993. As a researcher, he first investigated regional cerebral glucose metabolism in rats after chronic amphetamine administration and published the report in Psychiatry Research in 1995. From 1995, he cooperated with his colleague, Dr. JenPing Hwang, and published a serial of reports of geriatric psychopharmacology and behavioral/psychological symptoms of dementia. At the same time, he also did psychiatric and psychopharmacogentic studies with Dr. Chen-Jee Hong. As a Postdoctoral Fellow in Psychiatry Department, University of California, San Francisco (2004.7~2005.6), he studied neuroimaging. In recent years, he uses imaging technologies as phenotypic assays to evaluate how genes influence psychopathology and cognition. He is board certified in psychiatry and director of Taiwanese Society of Psychiatry. He has nearly 30 years of experience in psychiatric practice and research in psychiatric genetics, psychopharmacology and neuroimaging. Notably, Dr. Tsai has authored more than 400 peer-review scientific articles and four book chapters. Among them, 40 more reports are medical hypotheses about psychiatric diseases and treatment.60 more reports are related to brain-derived neurotrophic factor. His h-index is 52, based on Google Scholar; Citations: 10025 (December 2016). He presently serves on several journal editorial boards. SELECTED PUBLICATIONS [1] [2] [3] [4] [5] [6]
[7] [8] [9] [10] [11]
[12] [13] [14]
Chen MH, Tsai SJ. Treatment-resistant panic disorder: Clinical significance, concept and management. Prog Neuro-Psychopharmacol Biol Psychiatry 2016; 70: 219-26. Lin E, Kuo PH, Liu YL, Yang AC, Kao CF, Tsai SJ. Association and interaction of APOA5, BUD13, CETP, LIPA and health-related behavior with metabolic syndrome in a Taiwanese population. Sci Reports 2016; 6: 36830. Lin E, Tsai SJ. Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy. Prog Neuro-Psychopharmacol Biol Psychiatry 2016; 64: 334-40. Tsai SJ. Transcranial focused ultrasound as a possible treatment for major depression. Med Hypotheses 2015; 84(4): 381-3. Tsai SJ. Role of neurotrophic factors in attention deficit hyperactivity disorder. Cytokine Growth Factor Rev 2016. Yang AC, Hong CJ, Liou YJ, Huang KL, Huang CC, Liu ME, Lo MT, Huang NE, Peng CK, Lin CP, Tsai SJ. Decreased resting-state brain activity complexity in Schizophrenia characterized by both increased regularity and randomness. Hum Brain Mapp 2015; 36(6): 2174-86. Yang AC, Huang CC, Liu ME, Liou YJ, Hong CJ, Lo MT, Huang NE, Peng CK, Lin CP, Tsai SJ. The APOE epsilon4 allele affects complexity and functional connectivity of resting brain activity in healthy adults. Hum Brain Mapp 2014; 35(7): 3238-48. Hong CJ, Liou YJ, Tsai SJ. Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bulletin 2011; 86(5-6): 287-97. Tsai SJ, Hong CJ, Liou YJ. Recent molecular genetic studies and methodological issues in suicide research. Prog NeuroPsychopharmacol Biol Psychiatry 2011; 35(4): 809-17. Tsai SJ. Is autism caused by early hyperactivity of brain-derived neurotrophic factor? Med Hypotheses 2005; 65(1): 79-82. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet Part B: Neuropsychiatric Genetics 2003; 123B(1): 19-22. Tsai SJ. Attention-deficit hyperactivity disorder and brain-derived neurotrophic factor: A speculative hypothesis. Med Hypotheses 2003; 60(6): 849-51. Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 2002; 7(10): 1115-9. Tsai SJ, Huang YH, Chang LS, Yang YC, Sim CB. Alterations in local cerebral glucose utilization in rats after chronic amphetamine administration without subsequent challenge. Psychiatry Res 1995; 57(1): 65-73.
